With effect from 1 April 2026

At Singlife, we regularly review our Integrated Shield plans and riders to ensure they continue to support your healthcare and hospitalisation needs over time.

As part of this ongoing review, we have updated the benefits and premiums of our Singlife Shield and Singlife Health Plus plans to better support our customers while keeping pace with rising medical costs.

Premium Adjustments

Singlife Shield and Singlife Health Plus premiums
will be raised from 1 April 2026.

This adjustment reflects rising healthcare costs driven by medical inflation and higher healthcare utilisation. Advances in medical technology have resulted in more sophisticated and more expensive treatments, while higher manpower costs have added to cost pressures. In addition, Singapore’s ageing population has increased demand for medical care, resulting in higher claims frequency and overall claim costs.

For these reasons, we have revised the premiums for the following Singlife Shield plans and riders:
 

For the latest premium rates, please refer to the Singlife Shield and Singlife Health Plus premium table here.

New Recovery Support benefit

A new Recovery Support benefit will be introduced, offering coverage for 2 years per lifetime, capped at S$20,000 for home nursing care and rehabilitation services to provide continued support for long-term recovery.

To better support you on your recovery journey, customers who have both Singlife CareShield / ElderShield (Standard or Plus) and Singlife Health Plus , and who also qualify for the Severe Disability Benefit are eligible. This enhancement provides greater financial support for extended care needs, helping to ease the burden of long-term recovery and rehabilitation.

The Recovery Support benefit covers Home Personal Care Services provided by trained care professionals, as well as Rehabilitation Services such as physiotherapy, occupational therapy, and speech therapy, to support recovery and improve quality of life.

Increased coverage for
Singlife Shield Plan 2
[HIGHEST IN THE MARKET]

Singlife Shield Plan 2 policy year limit will be increased to S$1,200,000, providing greater coverage differentiation across Singlife Shield plans
to better meet your needs.

Revised Inpatient and Outpatient Cell, Tissue and Gene Therapy Benefit

The Cell, Tissue and Gene Therapy benefit
is revised to only cover the CTGTP if it is:

- Listed in the Benefit Schedule of the policy contract and the CTGTP List.
- Used according to the Cell, Tissue and Gene Therapy product-indication pairs
- Fulfils all clinical indication requirements as specified in the MOH Cell, Tissue and Gene Therapy Products (CTGTP) List.
 

If you are seeking higher cancer treatment coverage, you may consider
Singlife Cancer Cover Plus II to complement your existing plan.

¹We do not cover treatments on the CTGTP List unless they are listed in the benefit schedule and used in accordance with the specified clinical indications.

If you are under moratorium underwriting option

Customers who have policies terminated due to unpaid premiums may be required to go through full medical underwriting when submitting a request to reinstate their policy within 30 days from the date of notice of termination.

If a policy on moratorium underwriting is upgraded, it will no longer remain under moratorium and will undergo full medical underwriting.